BNP Paribas Financial Markets
TEVA icon

BNP Paribas Financial Markets’s Teva Pharmaceuticals TEVA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Sell
788,012
-89,556
-10% -$2.98M 0.01% 1101
2026
Q1 		$26.4M Buy
877,568
+316,337
+56% +$10.2M 0.01% 991
2025
Q4 		$17.5M Sell
561,231
-64,277
-10% -$1.58M 0.01% 1264
2025
Q3 		$12.6M Sell
625,508
-283,798
-31% -$4.98M 0.01% 1396
2025
Q2 		$15.2M Buy
909,306
+94,125
+12% +$1.52M 0.01% 1167
2025
Q1 		$12.5M Sell
815,181
-522,289
-39% -$9.33M 0.01% 1280
2024
Q4 		$29.5M Buy
1,337,470
+168,699
+14% +$3.07M 0.02% 853
2024
Q3 		$21.1M Sell
1,168,771
-548,003
-32% -$9.59M 0.01% 846
2024
Q2 		$27.9M Sell
1,716,774
-355,732
-17% -$5.48M 0.02% 634
2024
Q1 		$29.2M Buy
2,072,506
+645,353
+45% +$8.13M 0.03% 605
2023
Q4 		$14.9M Buy
1,427,153
+266,579
+23% +$2.49M 0.02% 836
2023
Q3 		$11.8M Sell
1,160,574
-189,435
-14% -$1.76M 0.02% 828
2023
Q2 		$10.2M Buy
1,350,009
+62,640
+5% +$508K 0.01% 910
2023
Q1 		$11.4M Sell
1,287,369
-19,352
-1% -$191K 0.02% 843
2022
Q4 		$11.9M Buy
1,306,721
+663
+0.1% +$5.79K 0.02% 888
2022
Q3 		$10.5M Buy
1,306,058
+179,402
+16% +$1.59M 0.02% 954
2022
Q2 		$8.47M Buy
1,126,656
+170,694
+18% +$1.49M 0.01% 982
2022
Q1 		$8.98M Sell
955,962
-645,538
-40% -$5.39M 0.01% 993
2021
Q4 		$12.8M Buy
1,601,500
+103,518
+7% +$934K 0.02% 845
2021
Q3 		$14.6M Sell
1,497,982
-584,008
-28% -$5.47M 0.02% 751
2021
Q2 		$20.6M Buy
2,081,990
+476,148
+30% +$5.04M 0.03% 636
2021
Q1 		$18.5M Sell
1,605,842
-220,048
-12% -$2.52M 0.03% 575
2020
Q4 		$17.6M Buy
1,825,890
+494,654
+37% +$4.74M 0.03% 550
2020
Q3 		$12M Buy
1,331,236
+210,058
+19% +$2.22M 0.02% 705
2020
Q2 		$13.8M Buy
1,121,178
+238,343
+27% +$2.7M 0.02% 589
2020
Q1 		$7.93M Sell
882,835
-166,414
-16% -$1.7M 0.02% 762
2019
Q4 		$10.3M Sell
1,049,249
-933,819
-47% -$8.34M 0.02% 824
2019
Q3 		$13.6M Buy
1,983,068
+161,100
+9% +$1.23M 0.02% 648
2019
Q2 		$16.8M Buy
1,821,968
+375,580
+26% +$4.53M 0.03% 518
2019
Q1 		$22.7M Buy
1,446,388
+27,240
+2% +$480K 0.05% 394
2018
Q4 		$21.9M Sell
1,419,148
-345,228
-20% -$7.08M 0.05% 392
2018
Q3 		$38M Sell
1,764,376
-103,334
-6% -$2.4M 0.06% 314
2018
Q2 		$45.4M Sell
1,867,710
-179,557
-9% -$3.66M 0.08% 250
2018
Q1 		$35M Sell
2,047,267
-37,702
-2% -$736K 0.07% 282
2017
Q4 		$39.5M Buy
2,084,969
+381,739
+22% +$5.74M 0.07% 263
2017
Q3 		$30M Buy
1,703,230
+661,710
+64% +$14.9M 0.07% 230
2017
Q2 		$34.6M Sell
1,041,520
-706,840
-40% -$21.9M 0.1% 186
2017
Q1 		$56.1M Buy
1,748,360
+237,310
+16% +$8.1M 0.15% 138
2016
Q4 		$54.8M Buy
1,511,050
+1,202,533
+390% +$48M 0.26% 73
2016
Q3 		$14.2M Buy
308,517
+88,350
+40% +$4.61M 0.06% 228
2016
Q2 		$11.1M Buy
220,167
+71,292
+48% +$3.8M 0.05% 265
2016
Q1 		$7.97M Sell
148,875
-28,215
-16% -$1.66M 0.03% 426
2015
Q4 		$11.6M Buy
177,090
+101,254
+134% +$6.26M 0.06% 267
2015
Q3 		$4.28M Sell
75,836
-96,813
-56% -$6.28M 0.01% 683
2015
Q2 		$10.2M Sell
172,649
-17,016
-9% -$1.05M 0.03% 359
2015
Q1 		$11.8M Buy
189,665
+89,959
+90% +$5.23M 0.03% 360
2014
Q4 		$5.73M Sell
99,706
-830,297
-89% -$46.3M 0.02% 607
2014
Q3 		$50M Buy
930,003
+819,091
+739% +$43.4M 0.04% 183
2014
Q2 		$5.81M Sell
110,912
-32,850
-23% -$1.68M 0.01% 611
2014
Q1 		$7.02M Sell
143,762
-38,199
-21% -$1.77M 0.01% 573
2013
Q4 		$12.5M Sell
181,961
-60,168
-25% -$2.37M 0.01% 413
2013
Q3 		$9.15M Buy
242,129
+26,044
+12% +$1.02M 0.01% 542
2013
Q2 		$8.47M Buy
+216,085
New +$8.42M 0.01% 376

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

BNP Paribas Financial Markets's TEVA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Teva Pharmaceuticals (TEVA) stake by 10% in Q2 2026, selling an estimated $2.98M and leaving 788,012 shares worth $26.7M. The position accounts for 0.01% of the portfolio, ranked #1101.

BNP Paribas Financial Markets first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.1M in Q1 2017. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • BNP Paribas Financial Markets held 788,012 shares of Teva Pharmaceuticals worth $26.7M as of Q2 2026.
  • BNP Paribas Financial Markets sold 89,556 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.98M.
  • Teva Pharmaceuticals made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1101 holding.
  • BNP Paribas Financial Markets first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • BNP Paribas Financial Markets's Teva Pharmaceuticals position peaked at $56.1M in Q1 2017.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.